RCKT
Rocket Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $415.43M | Price | $3.37 |
| Volume | 989.91K | Change | -5.48% |
| P/E Ratio | -1.6 | Open | $3.49 |
| Revenue | -- | Prev Close | $3.56 |
| Net Income | $-258.7M | 52W Range | $2.19 - $18.17 |
| Div Yield | N/A | Target | $7.52 |
| Overall | 47 | Value | 60 |
| Quality | 23 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyRocket Pharmaceuticals Inc. (RCKT) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.37 with a market capitalization of $415.43 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows RCKT with a volume of 990K shares. The stock opened down 1.97% from yesterday's close of $3.56. Current analyst estimates project earnings of $-2.06 per share for this year, with next year targeting $-1.35.
RCKT demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RCKT include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 123.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 08:52 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCKT | $3.37 | -5.5% | 989.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rocket Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW